"Could Adrecizumab be part of the answer to improve outcomes in cancer patients with septic shock? Adrenomedullin is known to be elevated in patients with GI and lung cancer as well as in Sepsis, the combination could be associated with worse outcomes."

enibarcimab (HAM 8101) - Adrenomed

Oct 16, 2021